MicroRNA Profiling of Morphologically Heterogeneous Clear Cell Renal Cell Carcinoma
Open Access
- 1 January 2021
- journal article
- research article
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 12 (18) , 5375-5384
Abstract
Intratumoral heterogeneity (IH) has been recently described as an important contributor to tumor growth through a branched rather than a linear pattern of tumor evolution for renal cell carcinoma. As to whether the miRNA profiling of the different and heterogeneous areas is the same or not, it is not known. This study analyzed the differences and similarities of the miRNA profiles in histologically distinct regions within several RCC tumors. The observed differences may have great implications for the development of predictive biomarkers and the identification of druggable targets with improvement of combinatorial therapeutic approaches for the effective treatment of kidney cancer, as well as for the identification of circulating malignant cells that can be useful to detect tumor recurrences.Keywords
This publication has 27 references indexed in Scilit:
- Combination of expression levels of miR-21 and miR-126 is associated with cancer-specific survival in clear-cell renal cell carcinomaBMC Cancer, 2014
- Cancer statistics, 2014CA: A Cancer Journal for Clinicians, 2014
- Comprehensive molecular characterization of clear cell renal cell carcinomaNature, 2013
- Tumor‐suppressive microRNA‐135a inhibits cancer cell proliferation by targeting the c‐MYC oncogene in renal cell carcinomaCancer Science, 2012
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion SequencingNew England Journal of Medicine, 2012
- MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapyNature Reviews Cancer, 2011
- Regulatory Effects of microRNA-92 (miR-92) on VHL Gene Expression and the Hypoxic Activation of miR-210 in Clear Cell Renal Cell CarcinomaJournal of Cancer, 2011
- Identification of a MicroRNA Panel for Clear-cell Kidney CancerUrology, 2010
- Metastatic Sarcomatoid Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted TherapyJournal of Clinical Oncology, 2009
- A MicroRNA Signature of HypoxiaMolecular and Cellular Biology, 2007